Transparency Market Research Report Added "Ocular Pain Market" to its database.
Albany, NY -- (SBWIRE) -- 02/22/2016 -- A new research report by Transparency Market Research (TMR) presents a comprehensive analysis of the global market for ocular pain. It states that the lack of hygiene consciousness among people across the world, which causes viral and bacterial ocular infections, is the key factor driving the growth of the global ocular pain market.
The market study, titled "Ocular Pain Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020," further projects that the rising awareness among people regarding eye-related disorders, coupled with the increasing disposable income worldwide, is likely to drive the growth of the global market for ocular pain over the forecast period.
The research report divides the global ocular pain market on the basis of its regional spread into North America, Asia Pacific, Europe, and the Rest of the World. Among these, North America and Europe dominated the global market in 2013 owing to the presence of a large number of market players.
Request for Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2718
Apart from this, the technical advancement in diagnosis procedures is also boosting the ocular pain market to a great extent. Analysts at TMR expect that favorable initiatives taken by several governments in North America and Europe to encourage the treatment of ocular pain and the increasing awareness pertaining to eye-related disorders among people will be fueling the ocular pain market in these regions during the forecast period, says the market study.
Further, the market report states that the Asia Pacific market for ocular pain has also exhibited remarkable growth in recent times owing to the rapid increase in the geriatric population base in the region. The untapped market in Asia Pacific is likely to present lucrative opportunities for market participants over the forecast period. The increase in the disposable income of people in this region is also projected to fuel the ocular pain market in Asia Pacific over the next few years.
On the other hand, the ocular pain market in the Rest of the World is anticipated to experience moderate growth, owing to the poor economic condition and healthcare infrastructure in many African economies. However, the infrastructural development in the medical and healthcare industry in Brazil and Mexico is likely to influence the Rest of the World market for ocular pain positively in the forthcoming years, notes the research study.
Sylentis S.A., InSite Vision Inc., Bayer AG, Reata Pharmaceuticals Inc., Bristol Meyer Squibb, Kala Pharmaceuticals Inc., and Merck and Co. are some of the major participants in the global ocular pain market, states the market report.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453